AERPIO PHARMACEUTICALS
Aerpio Pharmaceuticals is a new, clinical-stage biotechnology company focused on the development of novel small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Aerpio was created in a spin-out transaction from Akebia Therapeutics to enable more rapid development of its exciting compounds. It is managed by the same successful team from Akebia, employing a similar outsourced approach to pharmaceutical development. Aerpio Pharmaceuticals was founded in 2011 and is based in Cincinnati, Ohio, United States.
AERPIO PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.aerpio.com
Total Employee:
11+
Status:
Active
Contact:
(513) 985-1924
Total Funding:
107.54 M USD
Technology used in webpage:
Domain Not Resolving SPF IPv6 Cloudflare Hosting Cloudflare DNS MediaElement.js
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Araim Pharmaceuticals
Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
IMMvention Therapeutix
IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
MSTM
MSTM is an ionization innovation company that develops novel ionization techniques for mass spectrometry.
Phelix Therapeutics
Dedicated to saving the lives of people diagnosed with Idiopathic Pulmonary Fibrosis, and other Fibrotic Diseases.
Current Advisors List
Board_member
2014-04-01
Board_member
Board_member
2018-06-01
Board_member
2017-03-01
Board_member
2011-11-01
Board_member
Board_member
2017-03-01
Current Employees Featured
Ian A.W. Howes VP & CFO @ Aerpio Pharmaceuticals
VP & CFO
Kevin Peters Chief Scientific Officer @ Aerpio Pharmaceuticals
Chief Scientific Officer
Steve Pakola Chief Medical Officer @ Aerpio Pharmaceuticals
Chief Medical Officer
Adrienne L. Graves Independent Director @ Aerpio Pharmaceuticals
Independent Director
Jeffrey Sabados Program Management Support and Government Relations @ Aerpio Pharmaceuticals
Program Management Support and Government Relations
2019-01-01
Founder
Stock Details
Investors List
Athenian Venture Partners
Athenian Venture Partners investment in Venture Round - Aerpio Pharmaceuticals
Kearny Venture Partners
Kearny Venture Partners investment in Venture Round - Aerpio Pharmaceuticals
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners investment in Venture Round - Aerpio Pharmaceuticals
Venture Investors
Venture Investors investment in Venture Round - Aerpio Pharmaceuticals
Novartis Venture Fund
Novartis Venture Fund investment in Venture Round - Aerpio Pharmaceuticals
Ally Bridge Group
Ally Bridge Group investment in Venture Round - Aerpio Pharmaceuticals
Satter Investment Management
Satter Investment Management investment in Venture Round - Aerpio Pharmaceuticals
Montrose Capital Partners
Montrose Capital Partners investment in Venture Round - Aerpio Pharmaceuticals
OrbiMed
OrbiMed investment in Venture Round - Aerpio Pharmaceuticals
Athenian Venture Partners
Athenian Venture Partners investment in Venture Round - Aerpio Pharmaceuticals
Newest Events participated
Participated in 2017 CincyTech Big Breakfast + Startup Showcase
on 2017-11-08 as exhibitor
Official Site Inspections
http://www.aerpio.com Semrush global rank: 13.31 M Semrush visits lastest month: 78
- Host name: ec2-13-216-111-180.compute-1.amazonaws.com
- IP address: 13.216.111.180
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aerpio Pharmaceuticals"
Aerpio Pharmaceuticals - Crunchbase Company Profile & Funding
Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.See details»
Aadi Bioscience Announces Closing of Merger with Aerpio …
Aug 26, 2021 Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement Shares of Aadi to commence trading on the Nasdaq Capital Market …See details»
Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive ...
May 17, 2021 Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 for indications in which Aerpio believes that …See details»
aerpio.com
Aerpio.comSee details»
Aerpio Pharmaceuticals Announces Reverse Merger Agreement …
May 17, 2021 Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) has agreed to merge with a privately-held Aadi Bioscience. Following the proposed merger, the new entity will operate …See details»
Ohio's Top 19 Biopharmaceutical Firms - Inven
10. Aerpio Pharmaceuticals Website: aerpio.com Headquarters: Cincinnati, Ohio, United States Founded: 2011 Headcount: 11-50 Latest funding type: Ipo LinkedIn Aerpio Pharmaceuticals, …See details»
EX-99.1 - SEC.gov
The terms of the merger agreement contemplate that a non-transferable contingent value right ( CVR ) will be distributed to Aerpio shareholders as of immediately prior to the effective time of …See details»
Aerpio Pharmaceuticals, Inc. (Aerpio Pharmaceuticals, Inc.) - 药物 …
He was previously the CEO of Aerpio Pharmaceuticals, Inc. and Allos Therapuetics, Inc. and served as Managing Director at Skyline Ventures, as well as General Partner at TVM Capital.See details»
Aerpio Pharmaceuticals Announces Review of Strategic Alternatives
Oct 21, 2019 Aerpio Pharmaceuticals, Inc. (NasdaqCM: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular disease and diabetic …See details»
Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive ...
May 17, 2021 Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2, and Aadi Bioscience, Inc. …See details»
www.hospitals-management.com
About Aerpio Pharmaceuticals Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic …See details»
Aerpio Pharmaceuticals, Inc. (Form: 8-K, Received: 03/05/2021 …
Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, as well as other …See details»
Aerpio Pharmaceuticals (ARPO) - Market capitalization
As of February 2025 Aerpio Pharmaceuticals has a market cap of €0.10 Billion. This makes Aerpio Pharmaceuticals the world's 9007th most valuable company according to our data.See details»
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare …
May 27, 2020 About Aerpio Pharmaceuticals Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 to treat …See details»
Aerpio Pharmaceuticals DMF, CEP, Written Confirmations, FDF, …
Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. Our lead product candidate, AKB-9778, is a Tie2 activator …See details»
Aerpio Pharmaceuticals Inc (ARPO) - chartmill.com
Fundamental Analysis of Aerpio Pharmaceuticals Inc(NASDAQ:ARPO) stock. Fundamental Analysis of Growth, Valuation, Profitibility, Health and Dividend.See details»
All You Need To Know About Aerpio Pharmaceuticals, Inc. (ARPO) …
For Aerpio Pharmaceuticals, Inc. rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business.See details»
Aerpio and Quantum Leap Announce First Patients Dosed with
Sep 1, 2020 Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, …See details»
Carlisle v. Aerpio Pharmaceuticals, Inc. et al, 1:21-cv-01123, No. 1 …
` `On May 17, 2021 , Aerpio and Aadi jointly announced in relevant part: ` `CINCINNATI and PACIFIC PALISADES, Calif, May 17, 2021 (GLOBE `NEWSWIRE -— Aerpio …See details»
Aerpio shares plummet on eye study flop | Fierce Biotech
Mar 18, 2019 Shares in Aerpio Pharmaceuticals were more than halved in early trading this morning after it announced the failure of its leading drug candidate. The midstage test, known …See details»